127,95 €*
Versandkostenfrei per Post / DHL
auf Lager, Lieferzeit 1-2 Werktage
Thoroughly covers new treatment guidelines related to recent research and the latest physiologic understanding for a wide range of patients with hypertension and related co-morbidities.
Includes new chapters on Hypertension in Women, Mineralocorticoid Receptor Antagonists, Exercise and Hypertension, and Telemedicine/Digital Health.
Contains new or expanded content on epidemiology, pathophysiology, immunology, clinical findings, laboratory testing, invasive and non-invasive testing, risk stratification, clinical decision-making, prognosis, and management.
Provides new chapter summaries and a new focus on clinical and actionable content using a streamlined, narrative format.
Covers behavior management and prevention as an integral part of hypertensive and pre-hypertensive treatment plans.
Highlights combination drug therapies and management of chronic complications of hypertension.
Offers expert guidance from worldwide experts in cardiology, endocrinology, and nephrology, and integrates the most recent guidelines from leading organizations around the world.
An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date.
Thoroughly covers new treatment guidelines related to recent research and the latest physiologic understanding for a wide range of patients with hypertension and related co-morbidities.
Includes new chapters on Hypertension in Women, Mineralocorticoid Receptor Antagonists, Exercise and Hypertension, and Telemedicine/Digital Health.
Contains new or expanded content on epidemiology, pathophysiology, immunology, clinical findings, laboratory testing, invasive and non-invasive testing, risk stratification, clinical decision-making, prognosis, and management.
Provides new chapter summaries and a new focus on clinical and actionable content using a streamlined, narrative format.
Covers behavior management and prevention as an integral part of hypertensive and pre-hypertensive treatment plans.
Highlights combination drug therapies and management of chronic complications of hypertension.
Offers expert guidance from worldwide experts in cardiology, endocrinology, and nephrology, and integrates the most recent guidelines from leading organizations around the world.
An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date.
SECTION I: EPIDEMIOLOGY AND PREVENTIVE STRATEGIES 1. General Population and Global Cardiovascular Risk Prediction 2. Diet and Hypertension 3. Exercise and Hypertension 4. Hypertension in Women SECTION II: PATHOPHYSIOLOGY 5. Pathophysiology of Hypertension 6. Genetics of Hypertension 7. Inflammation and Immunity in Hypertension SECTION III: DIAGNOSIS AND EVALUATION 8. The Environment and High Blood Pressure 9. Office Blood Pressure Measurement 10. Home Monitoring of Blood Pressure 11. Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management 12. White Coat and Masked Hypertension 13. Renovascular Hypertension and ISchemic Neuropathy 14. Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States 15. Secondary Hypertension: Pheochromocytoma and Paraganglioma 16. Sleep Disruption and Blood Pressure SECTION IV: RISK STRATIFICATION 17. The Natural History of Untreated Hypertension 18. Isolated Systolic Hypertension 19. Assessment of Hypertension-Mediated Organ Damage SECTION V: ANTIHYPERTENSIVE THERAPY 20. Diuretics Therapy 21. Calcium Channel Blockers 22. Renin Angiotensin Aldosterone System Blockers 23. Aldosterone and Hypertension 24. ß-Blockers, Central Sympathetic Agents,and Direct Vasodilators 25. Peripheral Alpha Blockers 26. Initial Combination Therapies 27. Devices Therapies for Hypertension 28. The Treatment of Hypertension With Nutrition, Nutritional Supplements, and Lifestyle SECTION VI: HYPERTENSION MANAGEMENT APPROACHES 29. Approach to Difficult to Manage Primary Hypertension 30. Team-Based Care for Hypertension Management 31. Medication Adherence: Focus on Improvement 32. Digital Health and Telemedicine for Hypertension SECTION VII HYPERTENSION MANAGEMENT WITH COMORBIDITIES 33. Ischemic Heart Disease 34. Heart Failure 35. Hypertension and Chronic Kidney Disease Including Dialysis 36. Transplant Hypertension 37. Obesity and Hypertension: Pathophysiology and Treatment 38. Cerebrovascular Disease 39. Diabetes Mellitus: Management of Hypertension in Diabetes 40. Onco-Hypertension: Anticancer Therapy-Associated Hypertension 41. Autonomic Dysfunction and Orthostatic Hypotension 42. Dyslipidemia 43. Aorta and Peripheral Arterial Disease in Hypertension SECTION VIII SPECIAL POPULATIONS 44. Hypertension in Pregnancy 45. Hypertension in Older People 46. Hypertension in African Americans 47. Resistant Hypertension 48. Hypertensive Emergencies and Urgencies 49. Hypertension in Children: Diagnosis and Treatment Appendix Meta-Analyses of Blood Pressure Lowering Trials Index
Erscheinungsjahr: | 2024 |
---|---|
Fachbereich: | Chirurgie |
Genre: | Medizin |
Rubrik: | Wissenschaften |
Medium: | Buch |
Reihe: | Companion to Braunwald's Heart Disease |
ISBN-13: | 9780323883696 |
ISBN-10: | 0323883699 |
Sprache: | Englisch |
Einband: | Gebunden |
Redaktion: |
Bakris, George L.
Sorrentino, Matthew Laffin, Luke J. |
Auflage: | 4. Auflage |
Hersteller: |
Elsevier LTD
Elsevier Saunders W.B. |
Maße: | 282 x 220 x 28 mm |
Von/Mit: | George L. Bakris (u. a.) |
Erscheinungsdatum: | 04.01.2024 |
Gewicht: | 1,58 kg |
SECTION I: EPIDEMIOLOGY AND PREVENTIVE STRATEGIES 1. General Population and Global Cardiovascular Risk Prediction 2. Diet and Hypertension 3. Exercise and Hypertension 4. Hypertension in Women SECTION II: PATHOPHYSIOLOGY 5. Pathophysiology of Hypertension 6. Genetics of Hypertension 7. Inflammation and Immunity in Hypertension SECTION III: DIAGNOSIS AND EVALUATION 8. The Environment and High Blood Pressure 9. Office Blood Pressure Measurement 10. Home Monitoring of Blood Pressure 11. Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management 12. White Coat and Masked Hypertension 13. Renovascular Hypertension and ISchemic Neuropathy 14. Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States 15. Secondary Hypertension: Pheochromocytoma and Paraganglioma 16. Sleep Disruption and Blood Pressure SECTION IV: RISK STRATIFICATION 17. The Natural History of Untreated Hypertension 18. Isolated Systolic Hypertension 19. Assessment of Hypertension-Mediated Organ Damage SECTION V: ANTIHYPERTENSIVE THERAPY 20. Diuretics Therapy 21. Calcium Channel Blockers 22. Renin Angiotensin Aldosterone System Blockers 23. Aldosterone and Hypertension 24. ß-Blockers, Central Sympathetic Agents,and Direct Vasodilators 25. Peripheral Alpha Blockers 26. Initial Combination Therapies 27. Devices Therapies for Hypertension 28. The Treatment of Hypertension With Nutrition, Nutritional Supplements, and Lifestyle SECTION VI: HYPERTENSION MANAGEMENT APPROACHES 29. Approach to Difficult to Manage Primary Hypertension 30. Team-Based Care for Hypertension Management 31. Medication Adherence: Focus on Improvement 32. Digital Health and Telemedicine for Hypertension SECTION VII HYPERTENSION MANAGEMENT WITH COMORBIDITIES 33. Ischemic Heart Disease 34. Heart Failure 35. Hypertension and Chronic Kidney Disease Including Dialysis 36. Transplant Hypertension 37. Obesity and Hypertension: Pathophysiology and Treatment 38. Cerebrovascular Disease 39. Diabetes Mellitus: Management of Hypertension in Diabetes 40. Onco-Hypertension: Anticancer Therapy-Associated Hypertension 41. Autonomic Dysfunction and Orthostatic Hypotension 42. Dyslipidemia 43. Aorta and Peripheral Arterial Disease in Hypertension SECTION VIII SPECIAL POPULATIONS 44. Hypertension in Pregnancy 45. Hypertension in Older People 46. Hypertension in African Americans 47. Resistant Hypertension 48. Hypertensive Emergencies and Urgencies 49. Hypertension in Children: Diagnosis and Treatment Appendix Meta-Analyses of Blood Pressure Lowering Trials Index
Erscheinungsjahr: | 2024 |
---|---|
Fachbereich: | Chirurgie |
Genre: | Medizin |
Rubrik: | Wissenschaften |
Medium: | Buch |
Reihe: | Companion to Braunwald's Heart Disease |
ISBN-13: | 9780323883696 |
ISBN-10: | 0323883699 |
Sprache: | Englisch |
Einband: | Gebunden |
Redaktion: |
Bakris, George L.
Sorrentino, Matthew Laffin, Luke J. |
Auflage: | 4. Auflage |
Hersteller: |
Elsevier LTD
Elsevier Saunders W.B. |
Maße: | 282 x 220 x 28 mm |
Von/Mit: | George L. Bakris (u. a.) |
Erscheinungsdatum: | 04.01.2024 |
Gewicht: | 1,58 kg |